Coronavirus disease 2019 (COVID-19), a novel etiology of end-stage lung disease, has resulted in major disruptions to the process of health care delivery worldwide. These disruptions have led to team-based innovations globally, resulting in a broad range of new processes in cardiopulmonary perioperative management. A key intersection of multidisciplinary teamwork and COVID-19 is found in lung transplantation, in which diverse teams collaborate throughout the perioperative period to achieve optimal outcomes. In this article, we describe the multidisciplinary approach taken by Mayo clinic in Florida to manage patients with COVID-19 presenting for lung transplantation.
Keywords: ARDS, acute respiratory distress syndrome; CAD, coronary artery disease; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ESLD, end-stage lung disease; ICU, intensive care unit; MCF, Mayo clinic in Florida; MDT, multidisciplinary team; OR, operating room; PCR, polymerase chain reaction; POD, postoperative day; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; VA, veno-arterial; VV, veno-venous.
© 2022 The Authors.